Marshall Wace
ENTA icon

Marshall Wace’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.48M Buy
857,412
+6,522
+0.8% +$49.3K 0.01% 938
2025
Q1
$4.7M Sell
850,890
-79,197
-9% -$437K 0.01% 1021
2024
Q4
$5.35M Buy
930,087
+79,197
+9% +$455K 0.01% 946
2024
Q3
$8.82M Sell
850,890
-77,473
-8% -$803K 0.01% 731
2024
Q2
$12M Sell
928,363
-22,699
-2% -$294K 0.02% 590
2024
Q1
$16.6M Buy
+951,062
New +$16.6M 0.03% 509
2023
Q4
Sell
-74,810
Closed -$836K 1952
2023
Q3
$836K Buy
+74,810
New +$836K ﹤0.01% 1315
2022
Q3
Sell
-50,160
Closed -$2.37M 2688
2022
Q2
$2.37M Buy
+50,160
New +$2.37M ﹤0.01% 1517
2022
Q1
Sell
-9,670
Closed -$723K 2789
2021
Q4
$723K Buy
+9,670
New +$723K ﹤0.01% 2021
2021
Q1
Sell
-9,952
Closed -$419K 2212
2020
Q4
$419K Sell
9,952
-24,982
-72% -$1.05M ﹤0.01% 1406
2020
Q3
$1.6M Sell
34,934
-96,890
-73% -$4.43M 0.01% 835
2020
Q2
$6.62M Sell
131,824
-120,137
-48% -$6.03M 0.05% 375
2020
Q1
$13M Buy
251,961
+70,906
+39% +$3.65M 0.13% 162
2019
Q4
$11.2M Buy
181,055
+8,682
+5% +$536K 0.08% 272
2019
Q3
$10.4M Buy
172,373
+18,587
+12% +$1.12M 0.08% 269
2019
Q2
$13M Buy
153,786
+9,333
+6% +$788K 0.11% 207
2019
Q1
$13.8M Sell
144,453
-7,438
-5% -$711K 0.13% 197
2018
Q4
$10.8M Buy
151,891
+112,519
+286% +$7.97M 0.11% 222
2018
Q3
$3.37M Buy
+39,372
New +$3.37M 0.03% 552
2015
Q3
Sell
-26,016
Closed -$1.17M 958
2015
Q2
$1.17M Sell
26,016
-97,441
-79% -$4.38M 0.02% 570
2015
Q1
$3.78M Sell
123,457
-71,271
-37% -$2.18M 0.05% 367
2014
Q4
$9.9M Sell
194,728
-121,698
-38% -$6.19M 0.13% 196
2014
Q3
$12.5M Buy
316,426
+313,211
+9,742% +$12.4M 0.18% 152
2014
Q2
$138K Buy
+3,215
New +$138K ﹤0.01% 885